Intense <sup>18</sup>F-Flourodeoxyglucose Uptake in Brachial Plexus of Patients with Brachial Plexopathy
PDF
Cite
Share
Request
Interesting Image
P: 79-81
June 2020

Intense 18F-Flourodeoxyglucose Uptake in Brachial Plexus of Patients with Brachial Plexopathy

Mol Imaging Radionucl Ther 2020;29(2):79-81
1. Ankara University Faculty of Medicine, Department of Nuclear Medicine, Ankara, Turkey
2. Ankara University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey
No information available.
No information available
Received Date: 01.10.2018
Accepted Date: 13.02.2019
Publish Date: 29.04.2020
PDF
Cite
Share
Request

ABSTRACT

Brachial plexopathy is a significant cause of pain and disability in patients with breast cancer. Major causes of brachial plexopathy in patients with breast cancer are metastatic invasion or radiation damage to the plexus. Differentiation between the two pathologies is important for appropriate treatment planning. The complicated anatomy of the plexus makes this a difficult area to image accurately. Magnetic resonance imaging (MRI) is the imaging modality of choice for diagnostic evaluation of these cases. We presented a case to demonstrate the role of 18F-flourodeoxyglucose positron emission tomography/computerized tomography for confirming metastatic brachial plexopathy when MRI findings were suspicious and for differentiating radiation-induced brachial plexopathy from metastatic plexopathy.

References

1
Wood JJ, Gawler J, Whittle RJ, Staunton MD. Brachial plexopathy in breast carcinoma - An unsolved problem. Eur J Surg Oncol 1991;17:265-269.
2
Thyagarajan D, Cascino T, Harms G. Magnetic resonance imaging in brachial plexopathy of cancer. Neurology 1995;45:421‑427.
3
Ahmad A, Barrington S, Maisey M, Rubens RD. Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients. Br J Cancer 1999;79:478-482.
4
Madhavi T, Chandan D, Anurag S, Chandra Sekhar B. Metastatic brachial plexopathy in a case of recurrent breast carcinoma demonstrated on 18F-FDG PET/CT. Nucl Med Mol Imaging 2014;48:85-86.